Cargando…
Aiming for the Sweet Spot: Glyco-Immune Checkpoints and γδ T Cells in Targeted Immunotherapy
Though a healthy immune system is capable of recognizing and eliminating emergent cancerous cells, an established tumor is adept at escaping immune surveillance. Altered and tumor-specific expression of immunosuppressive cell surface carbohydrates, also termed the “tumor glycocode,” is a prominent m...
Autores principales: | Bartish, Margarita, del Rincón, Sonia V., Rudd, Christopher E., Saragovi, H. Uri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550643/ https://www.ncbi.nlm.nih.gov/pubmed/33133075 http://dx.doi.org/10.3389/fimmu.2020.564499 |
Ejemplares similares
-
CpG Adjuvant in Allergen-Specific Immunotherapy: Finding the Sweet Spot for the Induction of Immune Tolerance
por: Montamat, Guillem, et al.
Publicado: (2021) -
Editorial: Carbohydrates: The Yet to be Tasted Sweet Spot of Immunity
por: Coombe, Deirdre R., et al.
Publicado: (2015) -
Monitoring Circulating γδ T Cells in Cancer Patients to Optimize γδ T Cell-Based Immunotherapy
por: Oberg, Hans-Heinrich, et al.
Publicado: (2014) -
γδ T cells in immunotherapies for B-cell malignancies
por: Rimailho, Léa, et al.
Publicado: (2023) -
Cancer Immunotherapy Using γδT Cells: Dealing with Diversity
por: Scheper, Wouter, et al.
Publicado: (2014)